Clinical data | |
---|---|
Pronunciation | Leucovorin /ˌljuːkoʊˈvɔːrɪn/ |
Trade names | Many |
Other names | citrovorum factor, 5-formyltetrahydrofolate |
AHFS/Drugs.com | Monograph |
MedlinePlus | a608038 |
License data | |
Pregnancy category |
|
Routes of administration | Intravenous, IM, by mouth |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | Dose dependent |
Protein binding | ~15% |
Elimination half-life | 6.2 hours |
Excretion | Kidney |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.328 |
Chemical and physical data | |
Formula | C20H23N7O7 |
Molar mass | 473.446 g·mol−1 |
3D model (JSmol) | |
Melting point | 245 °C (473 °F) decomp |
Solubility in water | ~0.3[1] mg/mL (20 °C) |
| |
| |
(what is this?) (verify) |
Folinic acid, also known as leucovorin, is a medication used to decrease the toxic effects of methotrexate and pyrimethamine.[2][3] It is also used in combination with 5-fluorouracil to treat colorectal cancer and pancreatic cancer, may be used to treat folate deficiency that results in anemia, and methanol poisoning.[3][4] It is taken by mouth, injection into a muscle, or injection into a vein.[3]
Side effects may include trouble sleeping, allergic reactions, or fever.[2][3] Use in pregnancy or breastfeeding is generally regarded as safe.[2] When used for anemia it is recommended that pernicious anemia as a cause be ruled out first.[3] Folinic acid is a form of folic acid that does not require activation by dihydrofolate reductase to be useful to the body.[3]
Folinic acid was first made in 1945.[5] It is on the World Health Organization's List of Essential Medicines.[6]